Doctor profile · Federal record
Dr. Tanesha Washington
Family Nurse Practitioner · Gadsden, SC
- NPI 1811532278
- 7 yrs on file
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
246 Gay RD
Gadsden, SC 290529693
(803) 447-8102
Credentials & registration
- NPI registered
- November 2019 — 7 yrs on file
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- South Carolina #21332
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1811532278. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
120,866
Distinct HCPCS
10
Medicare allowed
$3,504,248
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3380 |
Injection, vedolizumab, 1 mg | 24,300 | 20 | $22 | |
J1306 |
Injection, inclisiran, 1 mg | 17,892 | 41 | $12 | |
J2357 |
Injection, omalizumab, 5 mg | 16,020 | 34 | $38 | |
J1439 |
Injection, ferric carboxymaltose, 1 mg | 15,750 | 13 | $1 | |
J0897 |
Injection, denosumab, 1 mg | 11,160 | 127 | $23 | |
J2350 |
Injection, ocrelizumab, 1 mg | 10,200 | 12 | $43 | |
J2356 |
Injection, tezepelumab-ekko, 1 mg | 9,660 | 11 | $18 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 5,370 | 25 | $33 | |
J3245 |
Injection, tildrakizumab, 1 mg | 4,500 | 16 | $139 | |
J9312 |
Injection, rituximab, 10 mg | 1,750 | 11 | $75 |
In context: peer comparison
Among 1 peers in Gadsden Family Nurse Practitioner, average services per provider: 5,755. This provider delivers 21× the peer median.Frequently asked questions
What is Dr. Tanesha Washington's medical specialty?
Dr. Tanesha Washington practices Family Nurse Practitioner in Gadsden, SC.
Where does Dr. Tanesha Washington practice?
Dr. Tanesha Washington practices at 246 Gay RD, Gadsden, SC 290529693. Office phone: 8034478102.
What is Dr. Tanesha Washington's NPI?
Dr. Tanesha Washington's National Provider Identifier (NPI) is 1811532278, issued by NPPES.
What procedures does Dr. Tanesha Washington commonly perform?
Top Medicare-reported procedures in 2023: Injection, vedolizumab, 1 mg (HCPCS J3380); Injection, inclisiran, 1 mg (HCPCS J1306); Injection, omalizumab, 5 mg (HCPCS J2357). Source: CMS Medicare Physician & Other Practitioners file.